Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02069015 · ClinicalTrials.gov registry record · NA

Achieving Blood Pressure Control Through Enhanced Discharge

A NA study of Hypertension, sponsored by Wayne State University.

Completed
Registry status
NA
Development phase
139
Enrollment target
1
Study location

NCT02069015 is a NA study of Hypertension that has completed, run by Wayne State University. The registered enrollment target is 139 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02069015, a NA study of Hypertension, has completed, sponsored by Wayne State University.

COMPLETED
Registry status
NA
Development phase
139 participants
Enrollment target
1
Study location

Study Summary

The primary aim of the study is to determine if enhanced discharge from the emergency department will improve blood pressure control and self-care management. Enhanced discharge will include a hypertension intervention delivered by a touch-screen kiosk over a three month period.

Conditions Studied

Interventions

  • BEHAVIORAL Patient education

Study Locations (1)

Michigan

  • Detroit Receiving Hospital Emergency Department - Detroit

Trial Details

FieldValue
Enrollment Target 139 participants
Start Date 2013-10
Est. Completion 2016-06
Phase NA

Sponsor

Wayne State University

163 total trials

What the Registry Record Tells You About NCT02069015

The ClinicalTrials.gov registry entry for NCT02069015 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 139 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (96% lower). The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Patient education is the first listed.

NCT02069015 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT02069015 about?

NCT02069015 is a clinical study titled "Achieving Blood Pressure Control Through Enhanced Discharge". The primary aim of the study is to determine if enhanced discharge from the emergency department will improve blood pressure control and self-care management. Enhanced discharge will include a hypertension intervention delivered by a touch-screen kiosk over a three month period.

What is the current status of trial NCT02069015?

This trial is currently completed. It is a NA study. The enrollment target is 139 participants. The study started on 2013-10. Estimated completion is 2016-06.

What conditions does trial NCT02069015 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT02069015?

The interventions under investigation include: Patient education (BEHAVIORAL).

Who is sponsoring clinical trial NCT02069015?

This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02069015 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.